Lowest Price Guaranteed
Slides
223
Last Updated
September 2025
View Count
19400
SECTION I: REPORT OVERVIEW
1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Introduction
2.4.2.2. Types
2.4.2.2.1. Qualitative
2.4.2.2.2. Quantitative
2.4.2.3. Advantages
2.4.2.4. Techniques
2.4.2.4.1. Interviews
2.4.2.4.2. Surveys
2.4.2.4.3. Focus Groups
2.4.2.4.4. Observational Research
2.4.2.4.5. Social Media Interactions
2.4.2.5. Stakeholders
2.4.2.5.1. Company Executives (CXOs)
2.4.2.5.2. Board of Directors
2.4.2.5.3. Company Presidents and Vice Presidents
2.4.2.5.4. Key Opinion Leaders
2.4.2.5.5. Research and Development Heads
2.4.2.5.6. Technical Experts
2.4.2.5.7. Subject Matter Experts
2.4.2.5.8. Scientists
2.4.2.5.9. Doctors and Other Healthcare Providers
2.4.2.6. Ethics and Integrity
2.4.2.6.1. Research Ethics
2.4.2.6.2. Data Integrity
2.4.3. Analytical Tools and Databases
3. MARKET DYNAMICS
3.1. Forecast Methodology
3.1.1. Top-Down Approach
3.1.2. Bottom-Up Approach
3.1.3. Hybrid Approach
3.2. Market Assessment Framework
3.2.1. Total Addressable Market (TAM)
3.2.2. Serviceable Addressable Market (SAM)
3.2.3. Serviceable Obtainable Market (SOM)
3.2.4. Currently Acquired Market (CAM)
3.3. Forecasting Tools and Techniques
3.3.1. Qualitative Forecasting
3.3.2. Correlation
3.3.3. Regression
3.3.4. Time Series Analysis
3.3.5. Extrapolation
3.3.6. Convergence
3.3.7. Forecast Error Analysis
3.3.8. Data Visualization
3.3.9. Scenario Planning
3.3.10. Sensitivity Analysis
3.4. Key Considerations
3.4.1. Demographics
3.4.2. Market Access
3.4.3. Reimbursement Scenarios
3.4.4. Industry Consolidation
3.5. Robust Quality Control
3.6. Key Market Segmentations
3.7. Limitations
4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Overview of Major Currencies Affecting the Market
4.2.2.2. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Exchange Impact
4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
4.2.6. Interest Rates
4.2.6.1. Overview of Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk
4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation
4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario
4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War
4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies
4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product (GDP)
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. R&D Innovation
4.2.11.7. Stock Market Performance
4.2.11.8. Supply Chain
4.2.11.9. Cross-Border Dynamics
SECTION II: QUALITATIVE INSIGHTS
5. EXECUTIVE SUMMARY
6. INTRODUCTION
6.1. Chapter Overview
6.2. Overview of Medical Cannabis
6.2.1. Key Characteristics of Medical Cannabis
6.2.2. Key Applications of Medical Cannabis
6.2.3. Challenges Associated with Medical Cannabis
6.3. Future Perspective
7. REGULATORY SCENARIO
SECTION III: MARKET OVERVIEW
8. COMPREHENSIVE DATABASE OF LEADING PLAYERS
9. COMPETITIVE LANDSCAPE
9.1. Chapter Overview
9.2. Medical Cannabis: Overall Market Landscape
9.2.1. Analysis by Year of Establishment
9.2.2. Analysis by Company Size
9.2.3. Analysis by Location of Headquarters
9.2.4. Medical Cannabis: Overall Market Landscape
9.2.4.1. Analysis by Product Type
9.2.4.2. Analysis by Source Type
9.2.4.3. Analysis by Species Type
9.2.4.4. Analysis by Derivative Type
9.2.4.5. Analysis by Route of Administration
9.2.4.6. Analysis by Application
9.2.4.7. Analysis by End User
10. PORTER'S FIVE FORCES ANALYSIS
11. COMPETITIVE COMPETITIVENESS ANALYSIS
12. STARTUP ECOSYSTEM IN THE MEDICAL CANNABIS MARKET
12.1. Medical Cannabis: Market Landscape of Startups
12.1.1. Analysis by Year of Establishment
12.1.2. Analysis by Company Size
12.1.3. Analysis by Company Size and Year of Establishment
12.1.4. Analysis by Location of Headquarters
12.1.5. Analysis by Company Size and Location of Headquarters
12.1.6. Analysis by Ownership Structure
12.2. Key Findings
SECTION IV: COMPANY PROFILES
13. COMPANY PROFILES
13.1. Chapter Overview
13.2. Aurora Cannabis
13.2.1. Company Overview
13.2.2. Company Mission
13.2.3. Company Footprint
13.2.4. Management Team
13.2.5. Contact Details
13.2.6. Financial Performance
13.2.7. Operating Business Segments
13.2.8. Product Portfolio
13.2.9. MOAT Analysis
13.2.10. Recent Developments and Future Outlook
13.3. Acreage Holdings (acquired by Canopy Growth)
13.4. Arcadia Biosciences
13.5. ADREXpharma
13.6. Babylon Sciences
13.7. Bedrocan International
13.8. Canopy Growth
13.9. Cara Therapeutics
13.10. CannaCare Health
13.11. DocMJ
13.12. Demecan
13.13. Dutch Harvest
13.14. Jazz Pharmaceuticals
13.15. Lexaria Bioscience
13.16. Medical Marijuana
13.17. PharmaCielo
13.18. Sensi Seeds
13.19. Tilray Brands
SECTION V: MARKET TRENDS
14. PATENT ANALYSIS
14.1. Chapter Overview
14.2. Scope and Methodology
14.3. Medical Cannabis: Patent Analysis
14.3.1. Analysis by Patent Publication Year
14.3.2. Analysis by Type of Patent and Patent Publication Year
14.3.3. Analysis by Patent Application Year
14.3.4. Analysis by Patent Jurisdiction
14.3.5. Analysis by CPC Symbols
14.3.6. Analysis by Type of Applicant
14.3.7. Leading Industry Players: Analysis by Number of Patents
14.3.8. Leading Individual Assignees: Analysis by Number of Patents
15. PARTNERSHIPS AND COLLABORATIONS
15.1. Chapter Overview
15.2. Partnership Models
15.3. Medical Cannabis: Partnerships and Collaborations
15.3.1. Analysis by Year of Partnership
15.3.2. Analysis by Type of Partnership
15.3.3. Analysis by Year and Type of Partnership
15.3.4. Analysis by Type of Partner
15.3.5. Analysis by Location of Headquarters of Partner
15.3.6. Analysis by Type of Partnership and Location of Headquarters of Partner
15.3.7. Most Active Players: Analysis by Number of Partnerships
15.3.8. Regional Analysis
15.3.8.1. Intercontinental and Intracontinental Deals
15.3.8.2. Local and International Deals
16. FUNDING AND INVESTMENTS ANALYSIS
16.1. Funding Models
16.2. Medical Cannabis: Funding and Investments
16.2.1. Analysis by Year of Funding
16.2.2. Analysis of Funding Instances by Type of Funding
16.2.3. Analysis of Funding Instances by Year and Type of Funding
16.2.4. Analysis of Amount Invested by Type of Funding
16.2.5. Analysis of Funding Instances by Country
16.2.6. Most Active Players: Analysis by Amount Raised
16.3. Summary and Key Takeaways
SECTION VI: MARKET OPPORTUNITY ANALYSIS
17. GLOBAL MEDICAL CANNABIS MARKET
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Trends Disruption Impacting Market
17.4. Demand Side Trends
17.5. Supply Side Trends
17.6. Global Medical Cannabis Market, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.7. Multivariate Scenario Analysis
17.7.1. Conservative Scenario
17.7.2. Optimistic Scenario
17.8. Investment Feasibility Index
17.9. Key Market Segmentations
18. MARKET OPPORTUNITIES BASED ON TYPE OF PRODUCT
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Revenue Shift Analysis
18.4. Market Movement Analysis
18.5. Penetration-Growth (P-G) Matrix
18.6. Medical Cannabis Market for Flower: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.7. Medical Cannabis Market for Concentrates: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.8. Medical Cannabis Market for Edible: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.9. Medical Cannabis Market for Topicals & Transdermal: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.10. Medical Cannabis Market for Other Products: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.11. Data Triangulation and Validation
18.11.1. Secondary Sources
18.11.2. Primary Sources
18.11.3. Statistical Modeling
19. MARKET OPPORTUNITIES BASED ON TYPE OF SOURCE
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Revenue Shift Analysis
19.4. Market Movement Analysis
19.5. Penetration-Growth (P-G) Matrix
19.6. Medical Cannabis Market for Natural: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.7. Medical Cannabis Market for Synthetic: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.8. Data Triangulation and Validation
19.8.1. Secondary Sources
19.8.2. Primary Sources
19.8.3. Statistical Modeling
20. MARKET OPPORTUNITIES BASED ON TYPE OF SPECIES
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Revenue Shift Analysis
20.4. Market Movement Analysis
20.5. Penetration-Growth (P-G) Matrix
20.6. Medical Cannabis Market for cannabis Indica: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.7. Medical Cannabis Market for Cannabis Sativa: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.8. Medical Cannabis Market for Hybrid: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.9. Data Triangulation and Validation
20.9.1. Secondary Sources
20.9.2. Primary Sources
20.9.3. Statistical Modeling
21. MARKET OPPORTUNITIES BASED ON TYPE OF DERIVATIVE
21.1. Chapter Overview
21.2. Key Assumptions and Methodology
21.3. Revenue Shift Analysis
21.4. Market Movement Analysis
21.5. Penetration-Growth (P-G) Matrix
21.6. Medical Cannabis Market for Cannabidiol: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.7. Medical Cannabis Market for Tetrahydrocannabidiol / Delta-8-Tetrahydrocannabinol: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.8. Medical Cannabis Market for Cannabicyclol: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.9. Medical Cannabis Market for Cannabinol: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.10. Medical Cannabis Market for Cannabigerol: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.11. Medical Cannabis Market for Cannabichromene: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.12. Medical Cannabis Market for Other Derivaties: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.13. Data Triangulation and Validation
21.13.1. Secondary Sources
21.13.2. Primary Sources
21.13.3. Statistical Modeling
22. MARKET OPPORTUNITIES BASED ON ROUTE OF ADMINISTRATION
22.1. Chapter Overview
22.2. Key Assumptions and Methodology
22.3. Revenue Shift Analysis
22.4. Market Movement Analysis
22.5. Penetration-Growth (P-G) Matrix
22.6. Medical Cannabis Market for Inhalation: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.7. Medical Cannabis Market for Oral: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.8. Medical Cannabis Market for Topical: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.9. Data Triangulation and Validation
22.9.1. Secondary Sources
22.9.2. Primary Sources
22.9.3. Statistical Modeling
23. MARKET OPPORTUNITIES BASED ON TYPE OF APPLICATION
23.1. Chapter Overview
23.2. Key Assumptions and Methodology
23.3. Revenue Shift Analysis
23.4. Market Movement Analysis
23.5. Penetration-Growth (P-G) Matrix
23.6. Medical Cannabis Market for Pain Management: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.7. Medical Cannabis Market for Neurological Health Management: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.8. Medical Cannabis Market for Mental Health Management: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.9. Data Triangulation and Validation
23.9.1. Secondary Sources
23.9.2. Primary Sources
23.9.3. Statistical Modeling
24. MARKET OPPORTUNITIES BASED ON TYPE OF DISTRIBUTION CHANNEL
24.1. Chapter Overview
24.2. Key Assumptions and Methodology
24.3. Revenue Shift Analysis
24.4. Market Movement Analysis
24.5. Penetration-Growth (P-G) Matrix
24.6. Medical Cannabis Market for Hospital Pharmacy: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.7. Medical Cannabis Market for Retail Pharmacy: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.8. Medical Cannabis Market for Online Pharmacy: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.9. Data Triangulation and Validation
24.9.1. Secondary Sources
24.9.2. Primary Sources
24.9.3. Statistical Modeling
25. MARKET OPPORTUNITIES BASED ON END USER
25.1. Chapter Overview
25.2. Key Assumptions and Methodology
25.3. Revenue Shift Analysis
25.4. Market Movement Analysis
25.5. Penetration-Growth (P-G) Matrix
25.6. Medical Cannabis Market for Hospitals: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
25.7. Medical Cannabis Market for Pharmaceutical Companies: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
25.8. Medical Cannabis Market for Research and Development Institutes: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
25.9. Medical Cannabis Market for Rehabilitation Centers: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
25.10. Medical Cannabis Market for Other End Users: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
25.11. Data Triangulation and Validation
25.11.1. Secondary Sources
25.11.2. Primary Sources
25.11.3. Statistical Modeling
26. MARKET OPPORTUNITIES FOR MEDICAL CANNABIS IN NORTH AMERICA
26.1. Chapter Overview
26.2. Key Assumptions and Methodology
26.3. Revenue Shift Analysis
26.4. Market Movement Analysis
26.5. Penetration-Growth (P-G) Matrix
26.6. Medical Cannabis Market in North America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
26.6.1. Medical Cannabis Market in the US: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
26.6.2. Medical Cannabis Market in Canada: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
26.6.3. Medical Cannabis Market in Mexico: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
26.7. Data Triangulation and Validation
27. MARKET OPPORTUNITIES FOR MEDICAL CANNABIS IN EUROPE
27.1. Chapter Overview
27.2. Key Assumptions and Methodology
27.3. Revenue Shift Analysis
27.4. Market Movement Analysis
27.5. Penetration-Growth (P-G) Matrix
27.6. Medical Cannabis Market in Europe: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
27.6.1. Medical Cannabis Market in France: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
27.6.2. Medical Cannabis Market in Germany: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
27.6.3. Medical Cannabis Market in Italy: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
27.6.4. Medical Cannabis Market in Spain: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
27.6.5. Medical Cannabis Market in The UK: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
27.6.6. Medical Cannabis Market in Rest of the Europe: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
27.7. Data Triangulation and Validation
28. MARKET OPPORTUNITIES FOR MEDICAL CANNABIS IN ASIA-PACIFIC
28.1. Chapter Overview
28.2. Key Assumptions and Methodology
28.3. Revenue Shift Analysis
28.4. Market Movement Analysis
28.5. Penetration-Growth (P-G) Matrix
28.6. Medical Cannabis Market in Asia-Pacific: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
28.6.1. Medical Cannabis Market in China: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
28.6.2. Medical Cannabis Market in India: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
28.6.3. Medical Cannabis Market in Japan: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
28.6.4. Medical Cannabis Market in South Korea: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
28.6.5. Medical Cannabis Market in Australia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
28.6.6. Medical Cannabis Market in Russia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
28.6.7. Medical Cannabis Market in Thailand: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
28.6.8. Medical Cannabis Market in Malaysia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
28.6.9. Medical Cannabis Market in Indonesia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
28.6.10. Medical Cannabis Market in Rest of the Asia-Pacific: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
28.7. Data Triangulation and Validation
29. MARKET OPPORTUNITIES FOR MEDICAL CANNABIS IN MIDDLE EAST AND NORTH AFRICA (MENA)
29.1. Chapter Overview
29.2. Key Assumptions and Methodology
29.3. Revenue Shift Analysis
29.4. Market Movement Analysis
29.5. Penetration-Growth (P-G) Matrix
29.6. Medical Cannabis Market in Middle East and North Africa (MENA): Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
29.6.1. Medical Cannabis Market in Iran: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
29.6.2. Medical Cannabis Market in Saudi Arabia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
29.6.3. Medical Cannabis Market in Egypt: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
29.7. Data Triangulation and Validation
30. MARKET OPPORTUNITIES FOR MEDICAL CANNABIS IN LATIN AMERICA
30.1. Chapter Overview
30.2. Key Assumptions and Methodology
30.3. Revenue Shift Analysis
30.4. Market Movement Analysis
30.5. Penetration-Growth (P-G) Matrix
30.6. Medical Cannabis Market in Latin America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
30.6.1. Medical Cannabis Market in Brazil: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
30.6.2. Medical Cannabis Market in Argentina: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
30.6.3. Medical Cannabis Market in Rest of Latin America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
30.7. Data Triangulation and Validation
31. ADJACENT MARKET ANALYSIS
SECTION VII: STRATEGIC TOOLS
32. KEY WINNING STRATEGIES
33. VALUE CHAIN ANALYSIS
34. ROOTS STRATEGIC RECOMMENDATIONS
SECTION VIII: OTHER EXCLUSIVE INSIGHTS
35. INSIGHTS FROM PRIMARY RESEARCH
36. REPORT CONCLUSION
SECTION IX: APPENDIX
37. TABULATED DATA
38. LIST OF COMPANIES AND ORGANIZATIONS
39. CUSTOMIZATION OPPORTUNITIES
40. ROOTS SUBSCRIPTION SERVICES
41. AUTHOR DETAILS